IMM Ann: Positive Final Data in 2nd Line Metastatic NSCLC Patients - 31st Mar 2023, 5:47pm

annb0t

annb0t

Top 20
IMM Ann: Positive Final Data in 2nd Line Metastatic NSCLC Patients
Price Sensitive: Y
Date: 31st Mar 2023, 5:47pm

>>> Read announcement: Google: IMM Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IMM Ann: Immutep receives positive scientific advice from EMA - 1st Aug 2023, 12:10pm
Replies
0
Views
74
annb0t
annb0t
annb0t
IMM Ann: Positive final data in 2nd line head and neck cancer at ASCO - 5th Jun 2023, 8:41am
Replies
0
Views
107
annb0t
annb0t
annb0t
IMM Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial - 6th Jun 2022, 8:20am
Replies
0
Views
233
annb0t
annb0t
annb0t
IMM Ann: Immutep Quarterly Activities Report and Appendix 4C - 31st Oct 2023, 8:43am
Replies
0
Views
86
annb0t
annb0t
annb0t
IMM Ann: Annual Report filed on Form 20-F with SEC - 25th Oct 2023, 11:01am
Replies
0
Views
86
annb0t
annb0t
Top Bottom